The oral cavity is structurally considered to be an organ that provide double layers of protection simultaneously through secretory immunoglobulin A (S-IgA) from mucosal immunity and immunoglobulin (Ig) G antibodies (Abs) from gingival crevicular fluid (1-3). Although immunization via injection can induce an effective immune responses in the systemic immune systems, but not an antigen (Ag)specific mucosal immune responses. Therefore, in order to prevent oral infection, it is ideal to induce mucosal immunity and systemic immunity simultaneously. Chronic periodontitis reduces oral function by causing periodontal tissue destruction and bone resorption. Recently, chronic periodontitis has been reported to cause systemic diseases such as diabetes, aspiration pneumonia, and atherosclerosis, and their relationship has been investigated (4-9). Therefore, prevention of periodontitis is important for oral health and systemic health derived from the oral cavity. Currently 7 to 10 bacterial candidates have been claimed to be putative periodontal pathogens (10, 11). Among them, P. gingivalis is a keystone pathogen that is strongly associated with disease progression of chronic periodontitis. The reason for using GroEL as a vaccine antigen is that is can be found in most putative periodontopathic pathogens, including P.gingivalis, and it was reported to crossreact among bacterial antigens. Thus far, a positive relationship has been observed between levels of saliva IgA directed against GroEL and